Azitra AZTR
NYSE AZTR
$0.13 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Azitra (AZTR) Asset Writedowns and Impairment (2026)

Updated

Azitra (AZTR) recorded Asset Writedowns and Impairment of $623,532 in Q1 2026.

Analysis

Azitra (AZTR) Asset Writedowns and Impairment (2026) Analysis & Trends

For FY2024, Azitra reported Asset Writedowns and Impairment of $442,793, up 26.0% from FY2023.

  • Across earlier years, Asset Writedowns and Impairment came in at $351,360 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Azitra 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 623,532.00
API Access

Azitra Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AZTR&period=max&api_key=YOUR_API_KEY